CogNet AI-MT+

by MedCognetics  · Based in United States → — Unbiased AI Transforming Healthcare
Oncology Radiology

Regulatory Status Disclosed

Overview

CogNet AI-MT+ by Medcognetics is an advanced artificial intelligence-enabled software platform designed to enhance radiological workflows, specifically for Digital Breast Tomosynthesis (DBT) screening mammograms. The tool utilizes a machine learning algorithm to analyze mammography images and flag those suggestive of at least one suspicious finding at the exam level. This passive notification system enables MQSA qualified interpreting physicians to prioritize their worklist, thereby optimizing clinical efficiency and potentially reducing radiologist burnout.

The software integrates seamlessly into existing imaging and IT systems, such as PACS/Workstations, to facilitate worklist prioritization. It is built on a foundation of diverse global patient datasets, which helps to mitigate data bias and aims to improve diagnostic accuracy across various ethnicities. CogNet AI-MT+ is designed to be flexible in its deployment, offering options for on-premises installation, cloud-based access, or via the web. It provides immediate, high-quality image analysis, and with embedded deployment, it can eliminate latency, offering a cost-efficient solution by reducing the need for expensive hardware upgrades.

It is important to note that CogNet AI-MT+ functions as a prioritization-only tool and does not provide diagnostic information beyond triage. It does not remove images from the interpreting physician’s worklist and should not be used as a substitute for a full patient evaluation or relied upon for making or confirming diagnoses.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-enabled radiological computer-aided triage and notification
  • Analyzes Digital Breast Tomosynthesis (DBT) mammograms
  • Flags studies with suspicious findings for prioritized review
  • Integrates into existing imaging and IT systems (PACS/Workstation)
  • Workflow optimization and worklist prioritization
  • Trained on diverse global patient datasets to mitigate data bias
  • On-premises, cloud, or web deployment options
  • Enhanced image quality through AI-driven enhancements
  • Immediate analysis and results, especially with embedded deployment
  • Cost efficiency by reducing the need for hardware upgrades

Use Cases

  • Prioritizing mammography cases with suspicious findings for radiologists
  • Improving radiologists' capabilities and efficiency in reading mammograms
  • Reducing radiologist burnout by streamlining workflow
  • Supporting earlier identification of potentially suspicious findings in breast imaging
  • Managing increasing imaging volumes in radiology departments
  • Enhancing diagnostic accuracy across diverse patient populations

What Physicians Need to Know

Key Capabilities
CogNet AI-MT+ analyzes 3D mammography (DBT) exams to identify suspicious findings, enabling worklist prioritization and workflow optimization for radiologists. It also offers features like image denoising, motion suppression, and microcalcification enhancement (under development). The system is designed to detect early signs of cancer across diverse ethnicities.
Clinical Utility
The tool empowers radiologists with AI-driven triage, flagging suspicious cases for prioritized review to help manage increasing imaging volumes. It aims to improve cancer detection sensitivity and provide consistent breast density classification. Studies suggest AI can reduce the time to additional imaging and biopsy diagnosis.
Integration Options
CogNet AI-MT+ integrates into existing imaging and IT systems, supporting worklist prioritization within PACS or workstation workflows. It can be deployed on-premises, in the cloud, or via a web portal. MedCognetics also offers an embedded AI solution for mammography systems, utilizing medical-grade edge AI hardware.
Compliance Status
CogNet AI-MT+ has received U.S. FDA 510(k) clearance for radiological computer-aided triage and notification software (Product Code QFM).
Pricing Model
Specific pricing for CogNet AI-MT+ is not publicly disclosed by MedCognetics. However, AI tools for imaging and diagnostics generally range from $3 to $25 per study, with an average of $5-15 per study, often based on volume tiers.
User Experience
The system is designed for an integrated workflow, providing AI results as part of the hanging protocol via DICOM Secondary Capture or DICOM Structured Report, aiming for no extra clicks or separate screens.
Implementation Complexity
The system is designed to integrate into existing healthcare workflows without disruption. MedCognetics offers flexible deployment options including cloud, on-premises, and embedded solutions.
Evidence Base
CogNet AI-MT+ has been developed through collaboration with clinical leaders and trained on diverse global datasets from various regions, including the US, UK, Europe, Middle East, Asia, South America, and Africa, to ensure unbiased performance across patient populations. Research indicates that implementing AI can significantly reduce the time to additional imaging and biopsy diagnosis for breast cancer screening.
Physician Tip

CogNet AI-MT+ can be a valuable tool for prioritizing mammography workloads, especially with increasing imaging volumes. Its ability to flag suspicious DBT exams can help ensure timely review of critical cases. The unbiased AI, trained on diverse datasets, aims to provide consistent performance across various patient populations. Consider its integration capabilities with your existing PACS and workflow to optimize efficiency. The embedded AI option could offer immediate results and enhanced image quality directly within mammography systems.

CogNet AI-MT+ is designed to integrate seamlessly into existing radiology workflows. It supports integration with PACS and workstations, delivering AI results through DICOM Secondary Capture or Structured Reports. Deployment options include cloud, on-premises, and embedded solutions, offering flexibility based on institutional IT infrastructure and data governance requirements. Partnerships, such as with Laurel Bridge Software, further enhance secure data flow and workflow orchestration.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentFlexible Deployment
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

What the Web Says

CogNet AI-MT+ is an AI-powered software developed by MedCognetics designed to assist radiologists in managing increasing imaging volumes by flagging suspicious 3D mammography (DBT) exams for prioritized review. It has received FDA 510(k) clearance for radiological computer-aided triage and notification. The system aims to improve health equity through unbiased AI, having been trained on diverse global datasets to ensure consistent performance across various patient populations.

Overall: Positive

Strengths

  • Integrates into existing imaging systems and workflows, minimizing disruption.
  • Flags suspicious 3D mammography (DBT) exams for prioritized review, helping manage high volumes.
  • Aims to improve health equity through unbiased AI, trained on diverse global datasets.
  • FDA 510(k) cleared for radiological computer-aided triage and notification.
  • Can help identify subtle cancers and improve image quality.
  • Offers on-premises deployment, cost-efficiency, optimized workflows, and easier upgrades.

Limitations

  • No specific cons were identified in the provided search results.
  • Evidence for sensitivity and specificity is pending in some medical AI diagnostic hubs.
  • The system still requires full physician review for every examination.

Based on reviews from: reddit.com, medcognetics.com, reportablenews.com, virtushealthcarestaffing.com, blackfordanalysis.com, auntminnie.com, healthcareaiops.com, mpo-mag.com, healthcareittoday.com, parikhradiology.com, emergenresearch.com, reachmd.com, diagnosticimaging.com

Last updated: 2026-10-31

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CogNet AI-MT+

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Newsfile Corp.
MedCognetics Receives FDA 510(k) Clearance for CogNet AI-MT+
MedCognetics announced it received U.S. FDA 510(k) clearance for CogNet AI-MT+, an AI-enabled radiological computer-aided triage and notification software for breast imaging. The software is designed to integrate into existing imaging systems to help radiologists manage increasing imaging volumes by flagging suspicious 3D mammography exams for prioritized review.
2026-02
AuntMinnie.com
MedCognetics nabs FDA 510(k) clearance for CogNet AI-MT+
MedCognetics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CogNet AI-MT+ software platform, which is designed to improve radiologists' capabilities in medical imaging with computer-aided triage and notification. The platform, trained on a diverse global dataset, uses advanced AI and machine learning to detect early signs of cancer across all ethnicities.
2026-02
Signify Research
February 2026 Medical Imaging AI News Roundup
MedCognetics received FDA 510(k) clearance for CogNet AI-MT+, an AI triage software designed for analyzing 3D mammography exams. This was part of a roundup of medical imaging AI news for February 2026, which also included other regulatory clearances and industry updates.
2026-03
AuntMinnie.com
MedCognetics highlights AI image processing system for mammography
MedCognetics is highlighting the successful testing and implementation of its embedded AI image processing and cancer detection system for mammography, CogNet AI-MT. The system utilizes the NVIDIA IGX Orin medical-grade edge AI platform and MedCognetics' AI-powered software, which has been trained on a diverse global dataset.
2024-10
Healthcare IT Today
MedCognetics Obtains FDA Clearance for CogNet AI-MT+
MedCognetics obtained FDA clearance for CogNet AI-MT+, its radiology triage and notification software. This was noted in a healthcare IT news roundup, alongside other company news and regulatory updates in the industry.
2026-02
MedCognetics
MedCognetics Receives FDA Clearance for CogNet AI-MT+
MedCognetics announced it received FDA clearance for CogNet AI-MT+, which is part of its Intelligent Women's Health Platform. The company states that its solution increases efficiency and accuracy by allowing radiologists to manage their workflow and triage mammography cases based on suspicious findings.
unknown
FDA.gov
FDA 510(k) Premarket Notification for CogNet AI-MT+
The FDA lists the 510(k) Premarket Notification for CogNet AI-MT+ from Medcognetics, Inc. under regulation number 892.2080 and product code QFM. The applicant and correspondent information are also provided.
2026-10
AuntMinnie.com
CogNet AI-MT+ Triage and Notification Software
CogNet AI-MT+ triage and notification software by MedCognetics was listed as a semifinalist in the 'Best New Radiology Device' category for the 2026 Minnies awards. The Minnies recognize the best and brightest in medical imaging.
2026-10

Videos

Product demos, reviews, and walkthroughs for CogNet AI-MT+.

Loading videos...

View all on YouTube

Frequently Asked Questions

CogNet AI-MT+ is designed to integrate into existing imaging and IT systems, including PACS or workstation workflows. It analyzes 2D and 3D screening mammograms and flags suspicious exams for worklist prioritization, allowing for optimized clinical workflows without requiring extra steps or separate screens.
CogNet AI-MT+ has received U.S. FDA 510(k) clearance for radiological computer-aided triage and notification software under 21 CFR 892.2080, Class II, Product Code QFM. This clearance permits its commercialization and use in the United States for flagging suspicious 3D mammography (DBT) exams for prioritized review.
While CogNet AI-MT+ is trained on a diverse global dataset to reduce bias and ensure consistent performance across various patient populations and ethnicities, AI tools in general can have limitations. General concerns with AI in oncology include potential algorithmic bias if training data lacks diversity, and the risk of over-reliance on AI-generated outputs, emphasizing that AI should be a support tool, not a replacement for clinical judgment.
CogNet AI-MT+ is an embedded AI image processing and cancer detection system for mammography that provides immediate results and aims to improve image quality. Other AI tools in oncology offer various functionalities, such as enhancing precision medicine with real-world datasets, delivering tailored treatment options, or integrating with genomic sequencing. While some AI tools focus on risk prediction or automating tasks, CogNet AI-MT+ specifically focuses on triage and notification for mammogram images.
The provided information does not specify the pricing model for CogNet AI-MT+. However, implementation cost is a commonly reported barrier to AI adoption in breast cancer detection. For specific pricing and acquisition details, it would be necessary to contact MedCognetics directly.

Related Tools

SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
CerviCARE AI
NTL Healthcare
OB/GYN AI
CerviCARE AI is an AI-powered cervical cancer screening system that analyzes smartphone images of the cervix to predict findings, aiming for early detection.
Lumonus AI
Lumonus
Clinical Decision Support & Reference
Lumonus AI is an AI-powered software that assists healthcare providers with prescriptions, dosing, and treatment for cancer patients, with a module (Sigma) that suggests treatment protocols based on prior plans for similar patients.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.
Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.

See all Oncology AI tools →

More from Medcognetics

CogNet QmTRIAGE
MedCognetics
Oncology AI
MedCognetics CogNet QmTRIAGE is an FDA-cleared AI-powered software for breast cancer screening that triages mammography and DBT exams to prioritize suspicious cases for radiologists, aiming to improve early detection and reduce radiologist burnout.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.